|
2024
|
Invention
|
Combinations of checkpoint inhibitors and therapeutics to treat cancer.
The present disclosure a... |
|
2023
|
Invention
|
Combinations of checkpoint inhibitors and therapeutics to treat cancer.
A combination treatment ... |
|
2021
|
Invention
|
Optimally activated dendritic cells that induce an improved or increased anti-tumor immune respon... |
|
2020
|
Invention
|
In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, an... |
|
|
Invention
|
Generation of dendritic cells from monocytic dendritic precursor cells with gm-csf in the absence... |
|
2017
|
Invention
|
Quality assays for antigen presenting cells.
The present invention provides methods for evaluati... |
|
2016
|
Invention
|
Methods relating to activated dendritic cell compositions and immunotherapeutic treatments for su... |
|
2014
|
Invention
|
Combinations of checkpoint inhibitors and therapeutics to treat cancer. The present disclosure ar... |
|
|
P/S
|
Immune cells, namely cells for medical or veterinary use; Biotechnology preparations for the prev... |
|
|
P/S
|
Immune cells for medical and veterinary use namely biochemicals in the form of activated dendriti... |
|
|
P/S
|
Vaccines for humans. |
|
|
P/S
|
Vaccines. |
|
2013
|
Invention
|
Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis. Th... |
|
2012
|
Invention
|
Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy.
Methods and ... |
|
|
Invention
|
Compositions and methods for inducing the activation of immature monocytic dendritic cells.
The ... |
|
|
Invention
|
Administration of dendritic cells partially matured in vitro for the treatment of tumors.
The pr... |
|
2010
|
Invention
|
Tangential flow filtration devices and methods for leukocyte enrichment. The present invention pr... |
|
2008
|
Invention
|
Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response.
Th... |
|
|
Invention
|
Method to increase class i presentation of exogenous antigens by human dendritic cells.
Methods ... |
|
2006
|
Invention
|
Compositions and methods for inducing the activation of immature monocytic dendritic cells. The p... |
|
|
Invention
|
Compositions and methods for inducing the activation of immature monocytic dendritic cells.
|
|
|
Invention
|
Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses.
The present invention ... |
|
2004
|
Invention
|
Tangential flow filtration devices and methods for stem cell enrichment. The present invent... |
|
|
Invention
|
Tangential flow filtration devices and methods for stem cell enrichment. The present invention pr... |
|
|
Invention
|
Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis.
T... |
|
|
Invention
|
Cultured cd14+ antigen presenting cells.
The present invention provides isolated CD14+ antigen p... |
|
|
Invention
|
Cultured cd14+ antigen presenting cells. The present invention provides isolated CD14+ antigen pr... |
|
|
Invention
|
Method for induction of proliferation of natural killer cells by dendritic cells cultured with gm... |
|
2003
|
Invention
|
Administration of dendritic cells partially matured in vitro for the treatment of tumors. T... |
|
|
Invention
|
Administration of dendritic cells partially matured in vitro for the treatment of tumors. The pre... |
|
|
Invention
|
Tangential flow filtration devices and methods for leukocyte enrichment. The present invent... |
|
2002
|
Invention
|
Compositions and methods for priming monocytic dendritic cells and t cells for th-1response.
The... |
|
2001
|
P/S
|
Pharmaceutical preparations for use in the treatment of cancer |
|
2000
|
P/S
|
Vaccines |
